Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia

Dai Mei; Liu Xia; Chen Zongqian; Zhao Fei; Wang Zhangqin; Liu Kangyan; Yang Ping; Luo Yawen; Shen Youshu

doi:10.13406/j.cnki.cyxb.003271

您当前的位置：

首页 >

文章列表页 >

Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia

Clinical research | 更新时间：2025-10-21

- Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia
- Journal of Chongqing Medical University Vol. 48, Issue 7, Pages: 811-815(2023)
- 作者机构：
  
  遵义医科大学附属医院感染科，遵义 563000
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003271
  CLC： R512.62
- Received：13 February 2023，
  
  Revised：2023-06-15，
  
  Accepted：27 June 2023，
  
  Published：28 July 2023
- 稿件说明：
移动端阅览
代梅,刘霞,陈宗倩,等.血浆置换联合双重血浆分子吸附系统人工肝治疗肝衰竭高胆红素血症患者疗效研究[J].重庆医科大学学报,2023,48(7):811-815.

Dai Mei,Liu Xia,Chen Zongqian,et al.Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia[J].Journal of Chongqing Medical University,2023,48(7):811-815.
代梅,刘霞,陈宗倩,等.血浆置换联合双重血浆分子吸附系统人工肝治疗肝衰竭高胆红素血症患者疗效研究[J].重庆医科大学学报,2023,48(7):811-815. DOI： 10.13406/j.cnki.cyxb.003271.

Dai Mei,Liu Xia,Chen Zongqian,et al.Clinical effect of plasma exchange combined with double plasma molecular adsorption system in artificial liver support therapy for patients with liver failure and hyperbilirubinemia[J].Journal of Chongqing Medical University,2023,48(7):811-815. DOI： 10.13406/j.cnki.cyxb.003271.

摘要

目的

探讨血浆置换（plasma exchange，PE）联合双重血浆分子吸附系统（double plasma molecular adsorption system，DPMAS）即PE+DPMAS治疗前与第1次、第2次治疗后肝衰竭高胆红素血症患者的临床疗效。

方法

采用回顾性分析方法，选取2020年1月至2022年5月于遵义医科大学附属医院就诊的57名肝衰竭患者，根据采取的人工肝治疗模式不同将接受PE治疗的24例患者纳入对照组，接受PE+DPMAS的33例患者纳入实验组。收集2组治疗前与2次治疗后肝衰竭高胆红素血症患者的临床资料，观察并对比2组治疗前后肝功能、凝血功能、营养状况等指标变化情况。

结果

实验组与对照组治疗前总胆红素（total bilirubin，TBil）、丙氨酸转氨酶（alanine transaminase，ALT）、天冬氨酸转氨酶（aspartate aminotransferase，AST）、球蛋白（globulin，Glb）、纤维蛋白原（fibrinogen，FIB）与第1次、第2次治疗后比较差异均有统计学意义（

0.05），但实验组治疗比对照组治疗能更好地清除TBil、ALT、AST。2组治疗前、第1次治疗后、第2次治疗后TBil分别为（388.37±180.26） μmol/L vs. （382.37±151.39） μmol/L、（296.22±137.81） μmol/L vs. （310.76±113.57） μmol/L、（244.63±143.40） μmol/L vs. （293.91±149.77） μmol/L，差异无统计学意义（

0.05）。实验组治疗前与2次治疗后白蛋白比较差异均无统计学意义（

0.05），对照组比较差异均有统计学意义（

0.05）；实验组国际标准化比率（international normalized ratio，INR）治疗前与2次治疗后比较差异无统计学意义（

0.05），对照组比较差异有统计学意义（

0.05）。前白蛋白、白蛋白与纤维蛋白原第1次治疗后2组比较差异均有统计学意义（

0.05）；实验组与对照组不同治疗节点比较，TBil、血小板、Glb、ALT、AST差异均无统计学意义（

0.05）。

结论

2次PE+DPMAS治疗模式更能有效吸附和降低肝衰竭患者体内的胆红素和转氨酶，且对凝血功能、白蛋白影响小，是治疗高胆红素血症患者的有效手段。

Abstract

Objective

To investigate the clinical effect of plasma exchange（PE） combined with double plasma molecular adsorption system（DPMAS） in patients with liver failure and hyperbilirubinemia after the first and second times of treatment.

Methods

A retrospective analysis was performed for 57 patients with liver failure who attended our hospital from January 2020 to May 2022，and according to artificial liver support therapy，24 patients who received PE were enrolled as control group，while 33 patients who received PE+DPMAS were enrolled as experimental group. Clinical data were collected from the two groups of patients with liver failure and hyperbilirubinemia before and after two times of treatment，and the two groups were observed and compared in terms of the changes in liver function，coagulation function，nutritional status，and other indicators after treatment.

Results

Both the experimental group and the control group had significant changes in total bilirubin（TBil），alanine aminotransferase（ALT），aspartate aminotransferase（AST），globulin（Glb），and fibrinogen after the first and second times of treatment（

0.05），but the experimental group showed better clearance of TBil，ALT，and AST compared with the control group，and there was no significant difference in TBil between the experimental group and the control group before treatment［（388.37±180.26） μmol/L vs. （382.37±151.39） μmol/L，

0.05］，after the first time of treatment［（296.22±137.81） μmol/L vs. （310.76±113.57） μmol/L，

0.05］，and after the second time of treatment［（244.63±143.40） μmol/L vs. （293.91±149.77） μmol/L，

0.05］. There was no significant change in albumin in the experimental group before and after two times of treatment（

0.05），while there was a significant change in albumin in the control group（

0.05）；there was no significant change in international normalized ratio（INR） in the experimental group before and after two times of treatment（

0.05），while there was a significant change in INR in the control group（

0.05）. There were significant differences betw

een the two groups in prealbumin，albumin，and fibrinogen after the first time of treatment（

0.05），and there were no significant differences in TBil，platelet count，Glb，ALT，and AST between the experimental group and the control group at different time points of treatment（

0.05）.

Conclusion

The therapeutic paradigm of PE+DPMAS for two times is more effective in adsorbing and reducing bilirubin and aminotransferases in patients with liver failure，with little impact on coagulation function and albumin，and therefore，it is an effective method for the treatment of patients with hyperbilirubinemia.

关键词

Keywords

references

El-Agamy DS ， Shebl AM ， Shaaban AA . Modulation of d-galactosamine/lipopolysacharride-induced fulminant hepatic failure by nilotinib [J ] . Hum Exp Toxicol ， 2018 ， 37 （ 1 ）： 51 - 60 .

Junior Paschoal FM ， Nogueira RC ， Oliveira ML ， et al . Cerebral hemodynamic and metabolic changes in fulminant hepatic failure [J ] . Arq Neuropsiquiatr ， 2017 ， 75 （ 7 ）： 470 - 476 .

Alshamsi F ， Alshammari K ， Belley-Cote E ， et al . Extracorporeal liver support in patients with liver failure：a systematic review and meta-analysis of randomized trials [J ] . Intensive Care Med ， 2020 ， 46 （ 1 ）： 1 - 16 .

Chinese Society of Infectious Diseases Liver Failure and Artificial Liver Group ， Severe Liver Disease and Artificial Liver Group CSOH . Guideline for diagnosis and treatment of liver failure [J ] . Chin J Hepatol ， 2019 ， 27 （ 1 ）： 18 - 26 .

张秀灵，段志文，杨瑞东，等 . 血源紧张条件下血浆置换联合双重血浆分子吸附系统治疗早中期肝衰竭患者临床研究 [J ] . 实用肝脏病杂志， 2019 ， 22 （ 2 ）： 289 - 290 .

Zhang XL ， Duan ZW ， Yang RD ， et al . Plasma exchange combined with double plasma molecular adsorption system in treatment of patients with liver failure [J ] . J Pract Hepatol ， 2019 ， 22 （ 2 ）： 289 - 290 .

Guo XJ ， Wu FQ ， Guo WB ， et al . Comparison of plasma exchange，double plasma molecular adsorption system，and their combination in treating acute-on-chronic liver failure [J ] . J Int Med Res ， 2020 ， 48 （ 6 ）： 300060520932053 .

人工肝血液净化技术临床应用专家共识（2022年版） [J ] . 实用肝脏病杂志， 2022 ， 25 （ 3 ）： 457 - 468 .

Expert consensus on clinical application of artificial liver and blood purification（2022 edition） [J ] . J Pract Hepatol ， 2022 ， 25 （ 3 ）： 457 - 468 .

Yao J ， Li S ， Zhou L ， et al . Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure [J ] . J Clin Apher ， 2019 ， 34 （ 4 ）： 392 - 398 .

Shang J ， Wang MQ ， Wen Q ， et al . A novel prognostic model to predict outcome of artificial liver support system treatment [J ] . Sci Rep ， 2021 ， 11 （ 1 ）： 7510 .

Li MQ ， Ti JX ， Zhu YH ， et al . Combined use of non-biological artificial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome [J ] . World J Emerg Med ， 2014 ， 5 （ 3 ）： 214 - 217 .

Xu WX ， Li YM ， Wang L ， et al . Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure：a multicentre randomised controlled clinical trial [J ] . BMJ Open ， 2021 ， 11 （ 12 ）： e047690 .

Casulleras M ， Zhang IW ， López-Vicario C ， et al . Leukocytes，systemic inflammation and immunopathology in acute-on-chronic liver failure [J ] . Cells ， 2020 ， 9 （ 12 ）： 2632 .

Wu CC ， Peng WT ， Cheng D ， et al . Efficacy and economic evaluation of nonbiological artificial liver therapy in acute-on-chronic hepatitis B liver failure [J ] . J Clin Transl Hepatol ， 2023 ， 11 （ 2 ）： 433 - 440 .

Bai WJ ， Yao C ， Mao DW ， et al . The clinical efficacy of double plasma molecular absorption system combined with plasma exchange in the treatment of acute-on-chronic liver failure：a systematic review and Meta-analysis [J ] . J Healthc Eng ， 2022 ， 2022 ： 3139929 .

Xiao LL ， Xu XW ， Huang KZ ， et al . Artificial liver support system improves short-term outcomes of patients with HBV-associated acute-on-chronic liver failure：a propensity score analysis [J ] . Biomed Res Int ， 2019 ， 2019 ： 3757149 .

Chen JJ ， Huang JR ， Yang Q ， et al . Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure：a nationwide prospective multicenter study in China [J ] . Hepatobiliary Pancreat Dis Int ， 2016 ， 15 （ 3 ）： 275 - 281 .

García Martínez JJ ， Bendjelid K . Artificial liver support systems：what is new over the last decade? [J ] . Ann Intensive Care ， 2018 ， 8 （ 1 ）： 109 .

Zhou YD ， Yang L ， Han QF ， et al . Clinical effect of combined artificial extracorporeal liver support therapy for toxic hepatic failure [J ] . Chin J Ind Hyg Occup Dis ， 2017 ， 35 （ 1 ）： 51 - 53 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The therapeutic effects comparison between plasma exchange and hemoperfusion in treating pattents of thronic hepatitis with hyperbilirubinemia

Research advances in plasma exchange in treatment of neuromyelitis optica-related optic neuritis

Prognostic evaluation of a prediction model based on neutrophil/lymphocyte ratio and red blood cell distribution width of inflammatory factors on hepatitis B virus-related acute-on-chronic liver failure

Clinical study on treatment of severe hepatitis by plasma exchange

Diabetic demyelinating neuropathy:a report of five cases

Related Author

ZHANG Li-dan

et al

石小枫

Ye Shiyang

Wang Xiaolei

Peng Xuejiao

Liao Mingyan

Jiang Anli

Related Institution

Department of Infection,the Second Affiliated Hospital,Chongqing Medial University

Department of Ophthalmology，The First Affiliated Hospital of Army Medical University

Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University

Institute of Viral Hepatitis,Chongqing Medical University

重庆医科大学病毒性肝炎研究所

⁰